Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Gadobutrol

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Metadata Last Checked: February 18, 2026 | Last Modified: 2025-03-17
Gadobutrol is a prescription intravenous contrast agent used to enhance magnetic resonance imaging (MRI) scans, helping doctors visualize body structures more clearly. Manufactured by Fresenius Kabi USA, LLC, it's available in solution form with a concentration of 604.72 mg/mL in vials of 2 mL, 7.5 mL, 10 mL, or 15 mL. This gadolinium-based drug works by improving MRI contrast for better diagnosis. This information was generated using AI and is provided for informational and research purposes only.

Find Related Datasets

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov